Drug profile · INN
amlodipine maleate
AMVAZ
amlodipine maleate (AMVAZ) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Drug details — amlodipine maleate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
amlodipine maleate (AMVAZ) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is amlodipine maleate?
amlodipine maleate (AMVAZ) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amlodipine maleate?
AMVAZ is a marketed brand name for amlodipine maleate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amlodipine maleate?
amlodipine maleate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.